NCT05652686 2025-09-23A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)Phanes TherapeuticsPhase 1/2 Recruiting203 enrolled
NCT00682981 2016-07-21A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)Teva Branded Pharmaceutical Products R&D, Inc.Phase 1/2 Completed218 enrolled